Aurora Spine acquired an exclusive license to U.S. Patent No. 9,451,986, “Percutaneous sacroiliac joint implant and method for surgically inserting and securing the implant into the sacroiliac joint,” through an agreement with its inventor company, SILIF.
Aurora Spine will develop the EASiFX™ implant, featuring retaining and bone locking mechanisms to use in sacroiliac joint fixation. The posterior approach is intended to minimize distraction of the sacroiliac joint, and the procedure will offer less tissue disruption with decreased O.R. time and radiation exposure.
Source: Aurora Spine Corporation
Aurora Spine acquired an exclusive license to U.S. Patent No. 9,451,986, “Percutaneous sacroiliac joint implant and method for surgically inserting and securing the implant into the sacroiliac joint,” through an agreement with its inventor company, SILIF.
Aurora Spine will develop the EASiFX™ implant, featuring retaining and bone locking...
Aurora Spine acquired an exclusive license to U.S. Patent No. 9,451,986, “Percutaneous sacroiliac joint implant and method for surgically inserting and securing the implant into the sacroiliac joint,” through an agreement with its inventor company, SILIF.
Aurora Spine will develop the EASiFX™ implant, featuring retaining and bone locking mechanisms to use in sacroiliac joint fixation. The posterior approach is intended to minimize distraction of the sacroiliac joint, and the procedure will offer less tissue disruption with decreased O.R. time and radiation exposure.
Source: Aurora Spine Corporation
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.